Medical Marketing and Media

View more issues:

Articles in Aug 1999 issue of Medical Marketing and Media

• Physician Web use increases
• Quintiles rising; builds new center, acquires firms
• Rescind Roxane drug's approval?
  by Dickinson, James G
• Henney escalates field compliance
  by Dickinson, James G
• It's time we trained our product managers
  by Ross, Warren
• Political 'football' put into play? Medicare drug plan gets airing
• Medscape seals deals with CBS network, NDC health data
• FDA orders change in Rezulin labeling
  by Dickinson, James G
• Glaxo toll-free number in FDA trouble
  by Dickinson, James G
• Influenza proves costly, just consider the mark up
• U.K. drug prices to be cut under five-year government plan
• Xopenex hit with another violation letter
  by Dickinson, James G
• Abbott's Cylert gets revised black box
  by Dickinson, James G
• A eulogy for client/agency partnerships
  by Warrington, Clayton L
• J&J to merge with Centocor for $4.9 billion
• AMA accepts the inevitable: DTC ads are here to stay
• No names change for Celebrex for now
  by Dickinson, James G
• Schering cited for promo knocking singulair
  by Dickinson, James G
• Competing drug companies cooperate in a bold race for gene therapies
  by Liebman, Milton
• Rx retail sales grow
• DTC promotions push drugs for Merck, SmithKline, McNeil
• FDA topside reorganization final
  by Dickinson, James G
• Forest recalls sub-potent levothyroxine
  by Dickinson, James G
• need for product manager training: Somebody is doing something about it, The
  by Girondi, Robert A
• Glaxo gets support for flu drug
• Can't live on bread alone, but whole grains help, FDS says
• FDA makes it easier for generics
  by Dickinson, James G
• Using a trade show environment to reinforce brand and company perception
  by Anderson, Mary
• First quarter U.S. Rx drug prices up 4.2 percent
• Rapid rise in global OTC sales
• Petition seeks to block more clozapine generics
  by Dickinson, James G
• DDMAC: Lipitor materials fudge study results
  by Dickinson, James G
• As I see it: Marketers are 'laughing at the FDA'
  by Dickinson, James G
• Novartis names new CEO
• Mysterious failure ousts Solvay drug
  by Dickinson, James G
• Half of all consumers read brief summary
  by Dickinson, James G
• Medscape joins Internet mania, readies initial stock offering
• drkoop.com links to AOL
• Harmful publicity: Petition hits FDA
  by Dickinson, James G
• Schein recalls entire Marsam inventory
  by Dickinson, James G
• New advertising campaigns: Zydone sales aid turns predator graphic into safety message
  by Castagnoli, William G
• Weight loss drugs get a boost
• AMA uses DTC ads to discuss formation of physicians' union
• Once an OTC candidate, Hismanal quits
  by Dickinson, James G
• Vioxx v. Celebrex: Round one
  by Dickinson, James G